Evidence map›Paper›PMID 39605294›Full record

ArticleJournal of cellular physiology2025

Spontaneously Immortalised Nonhuman Primate Müller Glia Cell Lines as Source to Explore Retinal Reprogramming Mechanisms for Cell Therapies.

Ahmed Salman, Arantxa Bolinches-Amorós, Tina Storm, Daniela Moralli, Paulina Bryika, Angela J Russell, Stephen G Davies, Alun R Barnard, Robert E MacLaren

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed SalmanNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK.ORCID 0000-0003-4300-2033
Arantxa Bolinches-AmorósNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK.
Tina StormNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK.
Daniela MoralliDepartment of Chemistry, University of Oxford, Oxford, Oxfordshire, UK.
Paulina BryikaDepartment of Chemistry, University of Oxford, Oxford, Oxfordshire, UK.
Angela J RussellWelcome Centre for Human Genetics, University of Oxford, Oxford, Oxfordshire, UK.
Stephen G DaviesDepartment of Pharmacology, University of Oxford, Oxford, Oxfordshire, UK.
Alun R BarnardNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK.
Robert E MacLarenNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, UK.

Funding

Funding was provided by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC, REM).
6 · The paper itself

Abstract

Cell replacement therapies for ocular diseases characterised by photoreceptors degeneration are challenging due to poor primary cell survival in culture. A stable retinal cell source to replace lost photoreceptors holds promise. Müller glia cells play a pivotal role in retinal homoeostasis by providing metabolic and structural support to retinal neurons, preventing aberrant photoreceptors migration, and facilitating safe glutamate uptake. In fish and amphibians, injured retinas regenerate due to Müller-like glial stem cells, a phenomenon absent in the mammalian retina for unknown reasons. Research on Müller cells has been complex due to difficulties in obtaining pure cell population and their rapid de-differentiation in culture. While various Müller glia cell lines from human and rats are described, no nonhuman primate Müller glia cell line is currently available. Here, we report spontaneously immortalised Müller glia cell lines derived from macaque neural retinas that respond to growth factors and expand indefinitely in culture. They exhibit Müller cells morphology, such as an elongated shape and cytoplasmic projections, express Müller glia markers (VIMENTIN, GLUTAMINE SYNTHASE, glutamate-aspartate transporter, and CD44), and express stem cell markers such as PAX6 and SOX2. In the presence of factors that induce photoreceptor differentiation, these cells show a shift in gene expression patterns suggesting a state of de-differentiation, a phenomenon known in reprogrammed mammalian Müller cells. The concept of self-renewing retina might seem unfeasible, but not unprecedented. While vertebrate Müller glia have a regeneration potential absent in mammals, understanding the mechanisms behind reprogramming of Müller glia in mammals could unlock their potential for treating retinal degenerative diseases.

Indexed as

Cell- and Tissue-Based TherapyCellular ReprogrammingEpendymoglial CellsNeurogliaRetinaAnimalsCell DifferentiationCell LineHumanscellular therapydifferentiationglianonhuman primate modelreprogrammingretinaself‐renewal

Identifiers

PMID39605294
PMCPMC11774137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.